Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 106
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

NEUROPILIN-1 INHIBITION SUPPRESSES NERVE-GROWTH FACTOR SIGNALING AND NOCICEPTION IN PAIN MODELS

NEUROPILIN-1 INHIBITION SUPPRESSES NERVE-GROWTH FACTOR ...

 87

CASP8 intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer’s disease risk

CASP8 intronic expansion identified by poly-glycine-arg...

 63

Maternal gut microbiota influence stem cell function in offspring

Maternal gut microbiota influence stem cell function in...

 75